Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP567511.RARc5cdo36HWKt_aDz6AsOFgwLSp0JUXqW2HNgc4pO6Zs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP567511.RARc5cdo36HWKt_aDz6AsOFgwLSp0JUXqW2HNgc4pO6Zs130_assertion type Assertion NP567511.RARc5cdo36HWKt_aDz6AsOFgwLSp0JUXqW2HNgc4pO6Zs130_head.
- NP567511.RARc5cdo36HWKt_aDz6AsOFgwLSp0JUXqW2HNgc4pO6Zs130_assertion description "[Severe combined immunodeficient mice bearing xenografts of transfected cell lines were used to assess the effect of VEGF overexpression and the effect of VEGF receptor (VEGFR) 2 inhibition on STS growth, metastasis, and response to doxorubicin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP567511.RARc5cdo36HWKt_aDz6AsOFgwLSp0JUXqW2HNgc4pO6Zs130_provenance.
- NP567511.RARc5cdo36HWKt_aDz6AsOFgwLSp0JUXqW2HNgc4pO6Zs130_assertion evidence source_evidence_literature NP567511.RARc5cdo36HWKt_aDz6AsOFgwLSp0JUXqW2HNgc4pO6Zs130_provenance.
- NP567511.RARc5cdo36HWKt_aDz6AsOFgwLSp0JUXqW2HNgc4pO6Zs130_assertion SIO_000772 16951193 NP567511.RARc5cdo36HWKt_aDz6AsOFgwLSp0JUXqW2HNgc4pO6Zs130_provenance.
- NP567511.RARc5cdo36HWKt_aDz6AsOFgwLSp0JUXqW2HNgc4pO6Zs130_assertion wasDerivedFrom befree-2016 NP567511.RARc5cdo36HWKt_aDz6AsOFgwLSp0JUXqW2HNgc4pO6Zs130_provenance.
- NP567511.RARc5cdo36HWKt_aDz6AsOFgwLSp0JUXqW2HNgc4pO6Zs130_assertion wasGeneratedBy ECO_0000203 NP567511.RARc5cdo36HWKt_aDz6AsOFgwLSp0JUXqW2HNgc4pO6Zs130_provenance.